Ifenprodil, sold under the brand names Cerocral, Dilvax, and Vadilex, is a cerebral vasodilator that has been marketed in some countries, including in Japan, Hong Kong, and France.

[7] Additionally, ifenprodil inhibits GIRK channels[8] and interacts with α1-adrenergic,[5] serotonin,[9] and sigma receptors.

[10][11][12][5] Chemically, ifenprodil is a substituted phenethylamine and β-hydroxyamphetamine derivative.

[1][2][3] Ifenprodil has been studied as a possible medication to prevent tinnitus after acoustic trauma.

[13] It is currently in phase II trials for cough and idiopathic pulmonary fibrosis, among other investigational uses.